Pacific Biosciences of California, Inc.
PACB
$1.13
$0.043.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 102.89% | 9.19% | -148.19% | 11.18% | 2.80% |
| Total Depreciation and Amortization | -6.41% | 195.12% | 193.77% | 166.03% | 157.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -355.31% | 86.12% | 493.43% | -50.43% | -17.86% |
| Change in Net Operating Assets | 208.10% | -37.10% | -240.43% | 41.23% | -36.22% |
| Cash from Operations | 46.75% | 30.25% | -30.00% | 20.07% | 4.96% |
| Capital Expenditure | 20.11% | 194.82% | 34.79% | -4.25% | 58.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 192.73% | -90.84% | 181.31% | 56.04% | -175.67% |
| Cash from Investing | 187.48% | -90.48% | 177.94% | 52.95% | -182.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11,180.90% | 100.00% | 67.31% | 24.22% | -3.97% |
| Issuance of Common Stock | -100.00% | -82.20% | -100.00% | -96.49% | -24.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 38.85% | -- | -- | -- | -- |
| Cash from Financing | 38.48% | 203.97% | 96.78% | -96.66% | -10,063.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.01% | -112.24% | 115.46% | -459.25% | -1,096.02% |